Clinical Trial Update: Efficacy of Nalbuphine and Naloxone Administered as Nose Sprays in the Treatment of Orofacial Pain [NA]

View source ↗

Summary

This ClinicalTrials.gov update reports on a terminated study evaluating intranasal nalbuphine with naloxone for orofacial pain and notes that results were poste…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Burning Mouth Syndrome
• Temporomandibular Joint Dysfunction Syndrome

Drugs mentioned

• Nalbuphine (nalbuphine)
• Naloxone (Naloxone)

Snippet

Sponsor: University of California, San Francisco | Conditions: Temporomandibular Joint Dysfunction Syndrome, Burning Mouth Syndrome | NA | Status: TERMINATED | Results posted: 2013-10-22